Combined essential oils demonstrate cytotoxic effects and reduced tumor volume in triple-negative breast cancer models, indicating enhanced anticancer potential.
Carvacrol, a phenolic monoterpene predominantly found in Origanum species, has been reported to exhibit antimicrobial, anti-inflammatory, antioxidant, and anticancer effects. Synergistic formulations such as Vacrol and S-Mix, enriched with carvacrol and complementary essential oil compounds, may enhance therapeutic efficacy while reducing toxicity. Essential oil components were analyzed via GC-MS. Cell viability was assessed using the sulforhodamine B (SRB) assay at different concentrations and incubation periods. An in ovo chorioallantoic membrane (CAM) assay was performed to investigate tumor volume changes and histopathological alterations. Vacrol and S-Mix demonstrated concentration- and time-dependent cytotoxic effects in MDA-MB-231 cells, with significant reductions in viability at higher concentrations (100 µM–1 mM). In ovo, S-Mix induced ~40% reduction in tumor volume and promoted apoptotic morphology compared to controls. Synergistic effects of carvacrol with α-pinene, eugenol, and β-terpineol likely contributed to enhanced bioactivity. Vacrol and S-Mix exhibit promising antiproliferative and pro-apoptotic activity against triple-negative breast cancer models. These findings support further preclinical and mechanistic investigations to validate their therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Geyik et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: